[EN] IMIDAZOPYRIDAZINE COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES [FR] COMPOSÉS IMIDAZOPYRIDAZINE UTILES EN TANT QUE MODULATEURS DE RÉPONSES À IL-12, IL-23 ET/OU IFNΑ
N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
申请人:Rodgers James D.
公开号:US20100298334A1
公开(公告)日:2010-11-25
The present invention relates to N-(hetero)aryl-pyrrolidine derivatives of Formula I:
which are JAK inhibitors, such as selective JAK1 inhibitors, useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.
[EN] A CLASS OF FIVE- AND SIX-MEMBERED HETEROCYCLIC COMPOUNDS AND USE THEREOF AS PROTEIN RECEPTOR KINASE INHIBITORS<br/>[FR] CLASSE DE COMPOSÉS HÉTÉROCYCLIQUES À CINQ ET SIX CHAÎNONS ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE PROTÉINE KINASE DU RÉCEPTEUR<br/>[ZH] 一类五元并六元杂环化合物及其作为蛋白受体激酶抑制剂的用途